Eden Alternatives: How GLP-1 Telehealth Options Compare

This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on GLP-1 therapies, weight management protocols, and the genetic variables that shape every metabolic decision. Browse all Peptides & GLP-1 education

Independent editorial review. PlexusDx holds no commercial relationship with Eden or its parent company, and nothing here is an affiliate placement or paid endorsement.

Full head-to-head: PlexusDx vs Eden →

If you are weighing Eden against the wider field of GLP-1 telehealth options, the useful question is not which brand shouts loudest but how the choices actually differ on format, price, and clinical scaffolding. This comparison maps where Eden sits and where PlexusDx fits alongside it. Fair-balance framing, not a purchase recommendation. Updated July 2026.

Where Eden sits in the GLP-1 telehealth landscape

Eden is a telehealth-plus-compounding operation: a licensed provider reviews an online intake, and, when eligibility is met, a prescription routes to a 503A compounding pharmacy for compounded semaglutide or tirzepatide, or to a retail pharmacy for an FDA-approved brand. Most alternatives in this category share that skeleton and differ mainly at the edges — provider type, pharmacy partner, and how the subscription is packaged. Review Eden’s official website for its current structure.

The formats Eden offers — and the ones it does not

One of the clearest lines between alternatives is delivery format. Eden dispenses injections only, bills strictly month to month with no multi-month plans, and prices by compound rather than by dose. Programs that add an oral route, longer commitment tiers, or dose-based pricing occupy a different corner of the same market. Knowing which axis matters to you narrows the field faster than any headline number.

How the alternatives differ on price and structure

Eden advertises $99/month for compounded semaglutide and $199/month for compounded tirzepatide as medication only; an active Eden Membership ($99/month, cut to $39 for the first month) is required to receive medication, so the true recurring figure is $198 all-in for semaglutide and $298 all-in for tirzepatide, with month one at $138 or $238 and nothing charged until a provider approves. A full year runs $2,376 or $3,576 at ongoing rates, and Eden adds a money-back warranty tied to losing 10% of body weight in six months. Eden figures verified at checkout, July 2026.

By contrast, PlexusDx runs month to month at $189 for Semaglutide Injection and $289 for Tirzepatide Injection, narrowly under Eden’s all-in figures, and adds Semaglutide Oral at $289/month and Tirzepatide Oral at $349/month — oral formats Eden does not carry. Confirm live pricing on each brand’s own site before committing.

The evidence every alternative leans on

Whichever brand fills the prescription, the pharmacology is the same class: GLP-1 receptor agonists such as semaglutide, liraglutide, and dulaglutide, and the GIP/GLP-1 dual agonist tirzepatide. The pivotal trial programs — STEP for semaglutide (The New England Journal of Medicine, 2021), SURMOUNT for tirzepatide (NEJM 2022), and SURMOUNT-OSA (NEJM 2024) — studied specific populations and endpoints. Individual outcomes vary.

The genetic layer no alternative maps

What separates the alternatives on paper is format and price; what none of them address is the upstream biology every GLP-1 compound acts on. Variants in FTO, the fat-mass and obesity-associated gene, along with GLP1R, MC4R, and TCF7L2, describe the metabolic terrain a clinician prescribes into. These markers are pathway-level and do not predict response to any specific drug. The Precision Peptide Genetic Test reads 14 pathways, 49 peptides, 150+ genetic insights across exactly this territory, so you can compare alternatives with your own baseline in view. PlexusDx offers both compounds through its Weight Management Protocols.

Not affiliated: PlexusDx has no relationship with Eden and does not represent the other companies referenced in this comparison.

Related reading on PlexusDx: GLP 1 Drugs, GLP 1 Hormone, What Is GLP 1, GLP 1 What Is.

Disclaimer: This article is educational. PlexusDx is not affiliated with Eden and has no commercial relationship with the companies compared here. The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways — it does not predict response to any specific medication. Consult a qualified healthcare provider before beginning any peptide protocol.

Weigh the PlexusDx option: explore the Weight Management Protocols, or start with the Precision Peptide Genetic Test to see your GLP-1 pathway before you pick a program.

Frequently Asked Questions

What are the main alternatives to Eden?

Alternatives fall into telehealth programs that dispense compounded semaglutide or tirzepatide and those routing FDA-approved brands through retail pharmacies. They differ by provider type, pharmacy partner, delivery format, and billing cadence. Compare those specifics rather than headline prices, and verify licensing on each brand’s own site.

Does Eden offer oral GLP-1 options?

As of July 2026, Eden dispenses injections only and bills month to month with no multi-month plans. Shoppers who prefer an oral route look to alternatives that carry that format. PlexusDx, for example, offers oral semaglutide and oral tirzepatide alongside injectable versions of both compounds.

How does PlexusDx differ from Eden as an alternative?

PlexusDx pairs its Weight Management Protocols with upstream genetic context most telehealth-only programs omit. It runs Semaglutide Injection at $189 and Tirzepatide Injection at $289 month to month, adds oral formats, and offers the Precision Peptide Genetic Test so decisions rest on pathway data, not brand marketing.

Can genetics help me choose between alternatives?

Genetic testing does not rank one program over another or predict how you will respond to a compound. It maps pathway-level variants such as FTO and GLP1R that describe your baseline metabolism — context that stays relevant no matter which alternative ultimately writes the prescription.

This article is part of the PlexusDx Education Hub. Browse all Peptides & GLP-1 education